Ricardo Vasquez, MD
Vascular Surgery · Bloomington, INNPI 1689622573
Payments from drug & device makers
What this record shows
This record is dominated by other: $70,259 of the $81,548 with a category attached, or 86.2%. Angiodynamics, Inc. accounts for 83.2% of it on its own, with 38 other manufacturers making up the rest. Among vascular surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 306 payments — averaging $266.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$68K
- Lemaitre Vascular, Inc.$4K
- Convatec Inc.$3K
- Johnson & Johnson$1K
- Abbott$777
- Philips North America LLC$763
- plus $4K from 33 others
What the payments were for
- Consulting fees$3,7055%
- Travel & lodging$6931%
- Food & beverage$6,8928%
- Other$70,25986%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 43 | $67,839 |
| Lemaitre Vascular, Inc. | 12 | $4,326 |
| Convatec Inc. | 1 | $3,092 |
| Johnson & Johnson(2 entities) | 63 | $1,083 |
| Abbott | 13 | $777 |
| Philips North America LLC | 27 | $763 |
| Silk Road Medical, Inc. | 7 | $617 |
| Boston Scientific | 12 | $542 |
| E.r. Squibb & Sons, L.L.C. | 38 | $509 |
| Tactile Systems Technology Inc | 21 | $302 |
| Endologix LLC | 2 | $259 |
| Kerecis Limited | 5 | $169 |
| Pfizer | 11 | $168 |
| Smith+Nephew | 7 | $116 |
| Chiesi USA, Inc. | 6 | $110 |
| Cordis US CORP. | 5 | $103 |
| Inari Medical, Inc. | 1 | $95 |
| Medtronic | 2 | $81 |
| Covidien LP | 3 | $58 |
| Venclose Inc. | 1 | $58 |
| Bolton Medical Inc | 2 | $52 |
| Bard Peripheral Vascular, Inc. | 3 | $44 |
| Avinger Inc. | 1 | $37 |
| Imperative Care, Inc | 1 | $37 |
| Cardiovascular Systems Inc. | 2 | $37 |
| Argon Medical Devices, Inc. | 2 | $30 |
| AstraZeneca | 2 | $27 |
| Baxter Healthcare | 1 | $22 |
| Neuros Medical, Inc. | 1 | $21 |
| Urgo Medical North America, LLC | 1 | $21 |
| Bsn Medical Inc | 1 | $20 |
| KCI USA, Inc. | 1 | $20 |
| GE HealthCare | 1 | $20 |
| Biocompatibles, Inc. | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $17 |
| Triad Life Sciences Inc. | 2 | $16 |
| Medline Industries LP | 1 | $15 |
| Cook Medical LLC | 1 | $12 |
| W. L. Gore & Associates, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$67,167
- VALVULOTOM$3,705
- InnovaMatrix AC$3,092
- ENROUTE Transcarotid Neuroprotection System$657
- Omnilink Elite vascular stent system$470
- ENROUTE Transcarotid Stent System$343
- ENHANCE Transcarotid Peripheral Access Kit$343
- ENROUTE 0.014 Guidewire$343
- ARTEGRAFT VASCULAR GRAFT$275
- Torus Stent Graft System$201
- ENDOCROSS Device$201
- Supera peripheral stent system$160
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$157
- ENROUTE Transcarotid Stent$157
- (6554) Periph Vasc Undiv$145
- XARELTO$122
- GENERAL VASCULAR INTERVENTION$103
How this compares
$81,548 in reported general payments places this provider in the 95th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 89 | $88,111 |
| EliquisApixaban | 12 | $12,285 |
| Cilostazol | 420 | $8,866 |
| ClopidogrelClopidogrel Bisulfate | 228 | $1,923 |
| Gabapentin | 48 | $665 |
| Simvastatin | 83 | $396 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $59 |
| Warfarin Sodium | 11 | $47 |
| Atorvastatin Calcium | 19 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $1,083 | $88,11189 claims |
| PfizerEliquis | $168 | $12,28512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Bloomington
- Raghunandan MotaganahalliBloomington$13K
- John MaijubBloomington$2K
- Andrew GonzalezBloomington$876
- John HamelinkBloomington$862
- Alan SawchukBloomington$410
- Michael ShaoFort Wayne$155K
- Sajjad HussainIndianapolis$109K
- Andres FajardoIndianapolis$58K
- Angela MartinEvansville$54K
- Luis GomezMishawaka$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.